Reported results
- CompoSecure reported record Adjusted Net Sales of $140.7 million, an increase of 16.4% year-over-year.
- CompoSecure reported record Pro Forma Adjusted EBITDA of $61.2 million, an increase of 22.9% year-over-year.
- CompoSecure Pro Forma Adjusted EBITDA Margin increased ~230bps year-over-year to 43.5%.
- Husky reported Adjusted Net Sales of $368.9 million, an increase of 0.5% year-over-year.
- Husky reported Pro Forma Adjusted EBITDA of $88.8 million, a decrease of 0.9% year-over-year.
- Husky Pro Forma Adjusted EBITDA Margin was 24.1% for the third quarter of 2026.
Guidance
- 4Q26 Pro Forma Adjusted Net Sales: $630 million – $660 million
- 4Q26 Pro Forma Adjusted EBITDA: $178 million – $208 million
- 4Q26 Pro Forma Adjusted EBITDA Margin: 27.0% – 29.0%
- FY26 Pro Forma Adjusted Net Sales: $2,034 million – $2,064 million
- FY26 Pro Forma Adjusted EBITDA: $520 million – $550 million
- FY26 Pro Forma Adjusted EBITDA Margin: 25.0% – 27.0%
- FY26 Pro Forma Adjusted Free Cash Flow: $250 million – $300 million
Notes
Effective February 28, 2025, GPGI accounts for the operating results of its wholly owned operating subsidiary, GPGI Holdings, L.L.C., under the equity method in accordance with U.S. GAAP due to the spin-off of Resolute Holdings and the execution of the CompoSecure Management Agreement.
Price and volatility reaction
The stock moved +6.6% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved +4.6 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 12.78 | 2026-11-04 |
| Close after release | 13.62 | 2026-11-05 |
| Realised move | +6.6% | close to close |
| 30d ATM IV change | +4.6 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
